- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Eosinophilic asthma (EA) is a type of rare and severe asthma, that usually comes on in adults. Usually, the effect of the treatment with corticosteroids is low, so therefore some biologic medicines have been approved and can be used to reduce eosinophilic asthma attacks.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
IL-5 |
Monoclonal Antibody |
Cinqaero® |
10 mg/mL |
– |
1 mg |
tba |
tba |
187,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin